Technology provider

CardioComm Solutions, Inc.

Technology provider

CardioComm Solutions, Inc.

CardioComm's ECG solution, based on mSafety, supports personal health monitoring for B2C markets as well as several enterprise models.

 

CardioComm Solutions, Inc. has released a wireless (BLE) handheld ECG monitor that pairs with the mSafety watch. The device is the HeartCheck™ CardiBeat which is cleared in Canada, the US and the EU as a Class II medical device that can be sold under physician direction or directly to consumers. The device can record a Lead I or Lead II ECG with a standard recording duration of 30 seconds.


Commercially, the HeartCheck™ CardiBeat is used with its free mobile application GEMS™ Mobile. The GEMS™ Mobile software has been embedded into the mSafety watch eliminating the need for the use of a smartphone. The total solution enables a user to activate the technology in the mSafety watch, record a 30 second ECG while holding the HeartCheck™ CardiBeat and to view the ECG on the mSafety watch during the recording.

 

Typical use cases include:

  • clinial trials
  • post-hospital discharge patient monitoring,
  • pharmacy-based ECG screening service for prolonged QT/c interval risk 

 

Cardiocomm slide

 

CardioComm's use of mSafety

Download an overview of how CardioComm uses Sony's mSafety.